Methylprednisolone Completed Phase 4 Trials for Relapsing Remitting Multiple Sclerosis (RRMS) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02205489Management Of The Infusion-Associated Reactions In RRMS Patients Treated With LEMTRADA
NCT00168766Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS
NCT00493116Is IFN-beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon Beta
NCT00492466Investigating if Interferon-Beta Can be Used in Patients With MS After They Have Developed Neutralizing Antibodies